MARKET

PTHS

PTHS

Pelthos Therapeutics
AMEX
20.60
+0.25
+1.23%
After Hours: 20.60 0 0.00% 19:30 10/02 EDT
OPEN
20.11
PREV CLOSE
20.35
HIGH
21.18
LOW
20.11
VOLUME
22.03K
TURNOVER
--
52 WEEK HIGH
37.50
52 WEEK LOW
18.19
MARKET CAP
78.87M
P/E (TTM)
-0.9439
1D
5D
1M
3M
1Y
5Y
1D
Pelthos Therapeutics Shareholders Back Directors and Equity Plan
TipRanks · 1d ago
Analysts Offer Insights on NA Companies: Flex (FLEX), Howard Hughes Holdings (HHH) and Pelthos Therapeutics (PTHS)
TipRanks · 4d ago
Weekly Report: what happened at PTHS last week (0921-0925)?
Weekly Report · 5d ago
Analysts Are Bullish on Top NA Stocks: International Paper Co (IP), Securitize (SECZ)
TipRanks · 09/21 11:30
Weekly Report: what happened at PTHS last week (0914-0918)?
Weekly Report · 09/21 10:20
Analysts’ Opinions Are Mixed on These NA Stocks: Beta Bionics, Inc. (BBNX) and Pelthos Therapeutics (PTHS)
TipRanks · 09/15 10:10
Weekly Report: what happened at PTHS last week (0907-0911)?
Weekly Report · 09/14 10:25
Analysts Offer Insights on NA Companies: Pelthos Therapeutics (PTHS) and X-Energy, Inc. Class A (XE)
TipRanks · 09/08 11:30
More
About PTHS
Pelthos Therapeutics Inc. is a biopharmaceutical company focused on commercializing therapeutic products for unmet patient needs. The Company's lead product, ZELSUVMI (berdazimer) topical gel, 10.3%, is used in the treatment of molluscum contagiosum infections (molluscum) in adults and pediatric patients one year of age and older. In addition to ZELSUVMI, the Company has a pipeline of product candidates that utilize its proprietary nitric oxide-based technology platform, NITRICIL. The Company’s product Xepi is a quinolone antimicrobial indicated for the topical treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients two months of age and older. Its NaV 1.7 is a clinical-stage assets which selectively target the sodium ion-channel. The Company also Xeglyze, which is a is a pediculicide indicated for the topical treatment of head lice infestation in patients six months of age and older.

Webull offers Pelthos Therapeutics Inc stock information, including AMEX: PTHS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTHS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTHS stock methods without spending real money on the virtual paper trading platform.